World of DTC Marketing

MARCH 10, 2022

AbbVie’s wall of patents protecting its top-selling drug Humira will keep another would-be competitor from entering the U.S. market until next year, with the pharmaceutical company announcing Tuesday a settlement with the Iceland-based Alvotech. The increase followed total Humira price hikes of 19 percent during 2017 and 2018.

Prescription 205

Prescription Pharmaceutical products Pharmaceutical Manufacturing 205

Clarivate

OCTOBER 31, 2023

What do the years 2001, 2007, 2014, and 2022 have in common? These years witnessed significant troughs in pharma financing, a drop in the capital markets, and an IPO window that remained firmly shut. a CGRP drug franchise, including the approved therapy Nurtec ODT, the only oral CGRP drug approved to prevent and treat migraines.

Pharma 52

Pharma Biopharma Marketing Healthcare 52

pharmaphorum

DECEMBER 15, 2022

A pharma industry organisation has warned that record levels of revenue clawback from the UK government is threatening “footprint, R&D and manufacturing investments” in the country. of total sales – under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) introduced in 2019. VPAS tax on top. .

Pharma 72

Pharma Government Manufacturing Competition 72

PM360

DECEMBER 20, 2023

With 2024 on the horizon, many in the biopharma space are taking stock of 2023 and what the current environment means for their potential success next year. What Will Revive the Dealmaking Situation? The longer that investment remains at suppressed levels, the more attritional the industry will be.

Biopharma 111

Biopharma Pharma Marketing Management 111

PM360

DECEMBER 20, 2023

At the close of Q3 2023, the SPDR S&P Biotech ETF (XBI), which tracks small and mid-size biotechs, was down 12% compared to the previous year while the S&P 500, an index tracking the stock performance of 500 of the largest companies in the U.S. This method is often quicker than a public offering and has less strict regulations.

Management 109

Management Marketing Healthcare Healthcare 109

PM360

DECEMBER 14, 2022

that didn’t stop us from asking 10 industry experts to take their best shot at anticipating what to expect in 2023 and beyond. Do you think this trend will prove impactful next year or in the near future or will it just be all talk? What can marketers start doing now to prepare for this change? Tyler Montague.

Marketing 91

Marketing Patients Healthcare Healthcare 91

Contrarian Sales Techniques

DECEMBER 14, 2022

The biotechnology and drug sectors performed well in the second half of 2022 after struggling in the first six months. Despite the uncertainty surrounding the global economy, the drug and biotechnology sectors have continued to perform well in the second half of 2022. What Influence the Future of the Large-Cap Pharma Industry?

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical Sales Medicine 52